
|Articles|February 1, 2023
Evonik debuts new synbiotics portfolio
Author(s)Jennifer Grebow
The new nutraceutical synbiotic line is called In Vivo Biotics.
Advertisement
Ingredients supplier Evonik (Essen, Germany) has launched a new nutraceutical range called In Vivo Biotics comprising synbiotic formulas that marry probiotics and other beneficial ingredients. The line includes In Vivo Biotics butyrate, which supports butyrate production; In Vivo Biotics resolvin; and In Vivo Biotics gluten tolerance.
“We believe the human microbiome has great potential for maintaining good health. That’s why we are thrilled to offer our customers science-based nutraceutical solutions like In Vivo Biotics,” said Maximillian Yeh, head of solutions at Evonik’s Health Care business, in a press release.
Advertisement
Advertisement
Advertisement
Trending on Nutritional Outlook - Supplement, Food & Beverage Manufacturing Trends
1
A New Frontier in Eye Health: Digital Wellness, Bioavailability, and the Eye-Brain Connection
2
Clasado Biosciences Partners with Prokopton SAS to Expand Bimuno GOS Distribution in France
3
Finished Product Clinical Validation Emerges as a Competitive Differentiator in the Supplement Industry
4
Lion’s Mane Ingredient Targets Standardized Erinacine A
5





